000 01244 a2200409 4500
005 20250517170002.0
264 0 _c20171214
008 201712s 0 0 eng d
022 _a1521-0464
024 7 _a10.1080/10717544.2017.1362677
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNie, Junpeng
245 0 0 _aCo-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects.
_h[electronic resource]
260 _bDrug delivery
_cNov 2017
300 _a1124-1138 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBortezomib
650 0 4 _aDocetaxel
650 0 4 _aHumans
650 0 4 _aLactic Acid
650 0 4 _aNanoparticles
650 0 4 _aNeoplasms
650 0 4 _aTaxoids
650 0 4 _aTissue Distribution
700 1 _aCheng, Wei
700 1 _aPeng, Yunmei
700 1 _aLiu, Gan
700 1 _aChen, Yuhan
700 1 _aWang, Xusheng
700 1 _aLiang, Chaoyu
700 1 _aTao, Wei
700 1 _aWei, Yinping
700 1 _aZeng, Xiaowei
700 1 _aMei, Lin
773 0 _tDrug delivery
_gvol. 24
_gno. 1
_gp. 1124-1138
856 4 0 _uhttps://doi.org/10.1080/10717544.2017.1362677
_zAvailable from publisher's website
999 _c27447377
_d27447377